Advertisement
CRDL vs LNTH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDL is a Hold and LNTH is a Buy.
CRDL sees its Stochastic Oscillator climbs out of oversold territory
On November 10, 2026, the Stochastic Oscillator for CRDL moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 71 instances where the indicator left the oversold zone. In 65 of the 71 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CRDL's RSI Oscillator exited the oversold zone, 19 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for CRDL just turned positive on October 23, 2026. Looking at past instances where CRDL's MACD turned positive, the stock continued to rise in 43 of 50 cases over the following month. The odds of a continued upward trend are 86%.
Following a +11.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRDL advanced for three days, in 178 of 220 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
CRDL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRDL as a result. In 85 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRDL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for CRDL entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.032) is normal, around the industry mean (6.379). P/E Ratio (-2.926) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (183.387).
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. CRDL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRDL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Aroon Indicator for LNTH shows an upward move is likely
LNTH's Aroon Indicator triggered a bullish signal on November 05, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 291 similar instances where the Aroon Indicator showed a similar pattern. In 250 of the 291 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on LNTH as a result. In 57 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
LNTH moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for LNTH crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.
Following a +1.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where LNTH advanced for three days, in 258 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LNTH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
LNTH broke above its upper Bollinger Band on November 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. LNTH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 41 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 44 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.008) is normal, around the industry mean (6.379). P/E Ratio (23.785) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (4.275) is also within normal values, averaging (183.387).
CRDL | LNTH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 30 | 10 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 56 Fair valued | 59 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 41 | |
SMR RATING 1..100 | 100 | 44 | |
PRICE GROWTH RATING 1..100 | 76 | 41 | |
P/E GROWTH RATING 1..100 | 22 | 34 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CRDL's Valuation (56) in the null industry is in the same range as LNTH (59) in the Medical Specialties industry. This means that CRDL’s stock grew similarly to LNTH’s over the last 12 months.
LNTH's Profit vs Risk Rating (41) in the Medical Specialties industry is somewhat better than the same rating for CRDL (100) in the null industry. This means that LNTH’s stock grew somewhat faster than CRDL’s over the last 12 months.
LNTH's SMR Rating (44) in the Medical Specialties industry is somewhat better than the same rating for CRDL (100) in the null industry. This means that LNTH’s stock grew somewhat faster than CRDL’s over the last 12 months.
LNTH's Price Growth Rating (41) in the Medical Specialties industry is somewhat better than the same rating for CRDL (76) in the null industry. This means that LNTH’s stock grew somewhat faster than CRDL’s over the last 12 months.
CRDL's P/E Growth Rating (22) in the null industry is in the same range as LNTH (34) in the Medical Specialties industry. This means that CRDL’s stock grew similarly to LNTH’s over the last 12 months.
| CRDL | LNTH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 83% | 1 day ago 76% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 74% |
| Momentum ODDS (%) | 1 day ago 85% | 1 day ago 72% |
| MACD ODDS (%) | 1 day ago 86% | N/A |
| TrendWeek ODDS (%) | 1 day ago 85% | 1 day ago 78% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 80% |
| Advances ODDS (%) | 4 days ago 81% | 3 days ago 79% |
| Declines ODDS (%) | 1 day ago 88% | 7 days ago 65% |
| BollingerBands ODDS (%) | 1 day ago 72% | 1 day ago 64% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 86% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CRDL’s FA Score shows that 1 FA rating(s) are green while LNTH’s FA Score has 0 green FA rating(s).
- CRDL’s FA Score: 1 green, 4 red.
- LNTH’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CRDL’s TA Score shows that 5 TA indicator(s) are bullish while LNTH’s TA Score has 5 bullish TA indicator(s).
- CRDL’s TA Score: 5 bullish, 3 bearish.
- LNTH’s TA Score: 5 bullish, 4 bearish.
Price Growth
CRDL (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while LNTH (@Pharmaceuticals: Generic) price change was +0.45% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.13%. For the same industry, the average monthly price growth was -6.49%, and the average quarterly price growth was +10.54%.
Reported Earning Dates
CRDL is expected to report earnings on Nov 12, 2026.
LNTH is expected to report earnings on Feb 25, 2027.
Industries' Descriptions
@Pharmaceuticals: Generic (-0.13% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
CRDL and
Correlation & Price change
A.I.dvisor tells us that CRDL and SNOA have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRDL and SNOA's prices will move in lockstep.
| Ticker / NAME | Correlation To CRDL | 1D Price Change % | ||
|---|---|---|---|---|
| CRDL | 100% | -0.98% | ||
| SNOA - CRDL | 29% Poorly correlated | +8.77% | ||
| LNTH - CRDL | 27% Poorly correlated | -0.02% | ||
| SCYX - CRDL | 26% Poorly correlated | -2.98% | ||
| KMDA - CRDL | 24% Poorly correlated | +0.37% | ||
| SNDL - CRDL | 23% Poorly correlated | +2.16% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IXN | 131.28 | 4.40 | +3.47% |
| iShares Global Tech ETF (IXN) | |||
| ACTS | 25.39 | 0.82 | +3.34% |
| FIS Tactical Equity ETF (ACTS) | |||
| TDVI | 30.91 | 0.62 | +2.05% |
| FT Vest Technology Dividend Target Income ETF (TDVI) | |||
| RAFE | 51.61 | 0.36 | +0.71% |
| PIMCO RAFI ESG U.S. ETF (RAFE) | |||
| QBQV | 25.67 | N/A | N/A |
| AllianzIM Growth-100 Buffer5 ETF (QBQV) | |||